Retour au classement

KIMBERLY-CLARK CORP (KMB)

NEUTRAL
Consumer DefensiveHousehold & Personal ProductsUnited States

Fondamental

56

Prix

$110.85

Capitalisation boursière

$37.04B

Partie 1 · Ce que vaut l'entreprise

Vue d'ensemble

Kimberly-Clark makes disposable personal-care and tissue products — diapers (Huggies), feminine and adult care, paper towels and toilet paper (Kleenex, Scott) — sold mainly through supermarkets, mass retailers and pharmacies. Its North America business is the larger and more profitable half; a separate International Personal Care unit sells largely the same categories outside the US and Canada. It is also folding in Kenvue (Tylenol, Band-Aid, Listerine) through a pending acquisition, and moving its non-US tissue business into a joint venture with Brazil's Suzano.

Comment l'entreprise gagne de l'argent

Kimberly-Clark sells everyday disposable products that customers repurchase every few weeks, so revenue depends on volume and price/mix rather than one-time big-ticket sales. It negotiates directly with a small number of very large retailers — Walmart alone is about 16% of net sales — who control shelf space and can push back hard on price increases, especially when store-brand alternatives sit right next to Kimberly-Clark's products. Profitability rises and falls largely with the cost of pulp, resin and other raw materials relative to what retailers accept in price increases.

Chiffre d'affaires par segment

North America65.85%

Personal care and tissue brands sold in the US and Canada, Kimberly-Clark's largest and most profitable market.

International Personal Care34.15%

Diapers, feminine and adult care products sold outside North America, largely in emerging markets.

Avantage concurrentiel

Marque · Étroit

Huggies, Kleenex and Scott are recognized household names that let Kimberly-Clark charge more than unbranded alternatives and secure shelf space with retailers. But private-label products sit right next to them at lower prices in every category it competes in, and large retailers hold real bargaining power over listing and price, so the brand premium is real but limited rather than dominant.

Ce qui stimule la demande

Défensif

Diapers, tissue and paper towels are bought regardless of the economic cycle, since consumers rarely cut back on basic hygiene products even in a downturn, which keeps volumes fairly stable. The bigger swing factor is the input-cost cycle — pulp, resin and energy prices — and retailers' willingness to accept the price increases needed to offset it, not end-consumer demand itself.

Principaux risques

  • Retailer bargaining power — A handful of very large retailers, led by Walmart, control the shelf space Kimberly-Clark depends on and can resist price increases or favor private-label alternatives.
  • Raw material cost volatility — Prices for pulp, resin, energy and other key inputs can rise sharply, and Kimberly-Clark may not be able to fully offset them through pricing without hurting volume.
  • Kenvue acquisition integration — The pending Kenvue acquisition will substantially increase debt and carries execution risk; the deal could also be delayed, face regulatory obstacles, or fail to deliver the expected synergies.
  • Private-label competition — Store-brand competitors, some with significantly lower development and manufacturing costs, offer comparable products at lower prices in nearly every category Kimberly-Clark serves.

Concentration des clients

Les principaux clients représentent 16% du chiffre d'affaires

Walmart alone accounted for approximately 16% of net sales from continuing operations in 2025, concentrated mostly in the North America segment; losing shelf space or favorable terms with a retailer this size would be difficult to replace elsewhere.

Les arguments en faveur

Buyers argue that Kleenex, Huggies and Scott are habitual purchases that hold their shelf position through economic cycles, that adding Kenvue's health-care brands diversifies the business beyond paper and diaper categories, and that shedding the lower-margin international tissue business into the Suzano joint venture should lift overall margins.

Les arguments contre

Sellers worry that the Kenvue deal loads the balance sheet with new debt right as Kimberly-Clark still has to prove the acquisition's synergies, that a handful of retailers led by Walmart can squeeze pricing whenever input costs rise, and that private-label alternatives keep gaining share in categories where the brand premium is hardest to defend.

Written by the editors, published on 18 août 2026

Direct competitors

Who this company fights with for the same customers

No editorial profile for this company yet

No competitor list for this company yet.

Bilan & Liquidités

Chiffre d'affaires

$16.58B

12 derniers mois (au 30/06/2026)

Résultat net

$1.96B

12 derniers mois (au 30/06/2026)

Flux de trésorerie libre

$1.64B

Capitaux propres totaux

$1.50B

Passif total

$15.47B

Ratio de liquidité général

0.91

Couverture des intérêts

9.18

Dette/EBITDA

2.06

Bénéfice par action

Chiffre d'affaires & Résultat net

Flux de trésorerie libre

Décomposition du résultat

État historique

Marges dans le temps

La dette dans le temps

Le poids de la dette

Grille de la croissance

Croissance — Chiffre d'affaires

Estimation de la juste valeur

Justement valorisé

Juste valeur

$105.17

Prix actuel

$110.85

Marge de sécurité

-5.4%

Fourchette de juste valeur

$69.32 - $141.03

Méthodes d'estimation

Analyst Target:$118.60
DCF:$151.08
PE-based:$74.03
Graham Growth:$37.85
EPV:$74.48
Consensus des analystes:Acheter (9B / 11H / 1S)
Dernière surprise sur les résultats:+4.20%

Indicateurs de valorisation

Ratio P/E

18.94

ROE

134.6%

Ratio P/B

21.17

P/FCF

20.35

Marge brute

36.8%

ROIC

18.6%

Radar de rentabilité

Value Creation (Economic Moat)

ROIC

18.6%

WACC

7.3%

ROIC − WACC

+11.4 pp

ROIC exceeds the cost of capital — the company is creating value for shareholders.

Critères d'analyse fondamentale

Réussi (15)

  • EPS shows upward trend
  • ROIC 18.6%
  • Gross Margin 36.8%
  • P/FCF 20.35
  • Operating Margin 14.3%
  • Positive Free Cash Flow
  • Current Ratio
  • Interest Coverage
  • Debt/EBITDA
  • Return on Tangible Assets
  • ROE 122.6%
  • Earnings Surprise avg 2.9%
  • Earnings Quality (OCF/NI) 1.70
  • Share Dilution -1.2%
  • Piotroski F-Score 5/9

Échoué (11)

  • EPS CAGR 2.23%
  • Price CAGR -0.43%
  • P/B Ratio 21.17
  • Debt/Equity ratio
  • CapEx intensity
  • Low reliance on intangibles
  • Price below Graham Number
  • DCF valuation (Fairly valued)
  • Revenue Growth 5Y -3.0%
  • Analyst Consensus 43% Buy
  • Net Margin Trend 11.8% vs 14.8%

Indisponible (2)

  • Dividend Payout NaN%
  • PEG Ratio (need PE > 0 and growth > 0)

Score F de Piotroski

5/9

Signaux mixtes : certains domaines nécessitent attention

score
criteria

Qualité des bénéfices

1.70

Qualité élevée : bénéfices soutenus par la trésorerie

Dilution du capital

-1.2%

Rachat d'actions. Favorable aux actionnaires

Gouvernance

Équipe dirigeante

NomTitreÂge
Mr. Michael D. HsuChairman & CEO61
Mr. Russell C. TorresPresident & COO53
Mr. Nelson UrdanetaSenior VP, CFO & Interim Principal Accounting Officer,53
Mr. Jeffrey P. Melucci J.D.Chief Strategy, Business Development & Administrative Officer54
Mr. Francesco TintoChief Information & Global Business Services Officer-
Mr. Christopher M. Jakubik C.F.A.Investor Relations Contact-
Mr. Grant B. McGee J.D.General Counsel44
Ms. Preeti BinoyHead Corporate Communications & Government Affairs - India-
Ms. Stacey J. Valy PanayiotouChief Human Resources Officer52
Mr. Ehab Abou-OafChief Executive Officer of Arbex58

Risque d'audit

3

Risque du conseil

5

Risque de rémunération

6

Risque droits des actionnaires

4

Partie 2 · Le prix et le moment d'entrer

Cette partie ne dit pas si l'entreprise vaut la peine : elle aide à choisir quand l'acheter, une fois que les fondamentaux vous ont convaincu. À l'intérieur : analyse technique, potentiel, baisses historiques, exposition gamma.

Latest News

Recent headlines for KMB, sourced from Markets Gazette.

No recent news for KMB.